NCT01258998 · OUTCOME
Number of Participants With Change in Biomarker Levels With p Values <0.05
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Baseline to up to 30 days post-treatment
What was measured
The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.
Groups in this outcome
Akt Inhibitor MK2206
Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
| Group | Source count |
|---|---|
| Akt Inhibitor MK2206 | 36 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Akt Inhibitor MK2206 | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 36
- units
- Participants
- description
- The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.
- groups
- description
- Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
- id
- OG000
- title
- Akt Inhibitor MK2206
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Baseline to up to 30 days post-treatment
- title
- Number of Participants With Change in Biomarker Levels With p Values <0.05
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle